Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
BJs Wholesale Club
BJ
$11.9B
| $43.7M | 0.04% |
+1,172,900
| New | +$36M |
|
477
Alliant Energy
LNT
$18.2B
| $43.6M | 0.04% |
911,304
-340,100
| -27% | -$16.6M |
|
|
THS
478
DELISTED
Treehouse Foods
THS
| $43.4M | 0.04% |
991,600
+896,400
| +942% | +$43.7M |
|
479
Shutterstock
SSTK
$217M
| $43.3M | 0.04% |
1,237,401
+285,501
| +30% | +$10.3M |
|
480
Baxter International
BAX
$14B
| $43M | 0.04% |
499,500
+447,798
| +866% | +$39M |
|
|
PFPT
481
DELISTED
Proofpoint, Inc.
PFPT
| $42.9M | 0.04% |
386,200
+205,800
| +114% | +$23.5M |
|
482
Calix
CALX
$2.51B
| $42.5M | 0.04% |
2,855,100
-149,118
| -5% | -$1.71M |
|
483
National Bank Holdings
NBHC
$1.94B
| $42.4M | 0.04% |
1,570,500
+48,900
| +3% | +$1.25M |
|
484
NewMarket
NEU
$8.72B
| $42M | 0.04% |
104,800
+14,200
| +16% | +$5.86M |
|
|
CCF
485
DELISTED
Chase Corporation
CCF
| $41.9M | 0.04% |
408,700
+3,100
| +0.8% | +$290K |
|
486
Central Garden & Pet Co Class A
CENTA
$2.41B
| $41.8M | 0.04% |
1,546,125
+91,375
| +6% | +$2.29M |
|
|
VRE
487
DELISTED
Veris Residential
VRE
| $41.5M | 0.04% |
2,711,721
-1,081,779
| -29% | -$16.8M |
|
|
DOCU
488
DocuSign
DOCU
$12.2B
| $41.4M | 0.04% |
240,200
+174,500
| +266% | +$22M |
|
489
Post Holdings
POST
$3.65B
| $41.3M | 0.04% |
720,758
+181,985
| +34% | +$10.6M |
|
490
GeoPark
GPRK
$608M
| $41.2M | 0.04% |
4,205,130
-183,862
| -4% | -$1.65M |
|
491
Bunge Global
BG
$21.7B
| $41.1M | 0.04% |
999,954
+281,028
| +39% | +$10.9M |
|
|
MNR
492
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $40.4M | 0.03% |
2,791,000
-400,700
| -13% | -$5.2M |
|
|
UHT
493
Universal Health Realty Income Trust
UHT
$573M
| $40.4M | 0.03% |
508,510
-42,100
| -8% | -$3.96M |
|
494
DaVita
DVA
$11.4B
| $40.4M | 0.03% |
510,322
-348,900
| -41% | -$27.2M |
|
495
Travere Therapeutics
TVTX
$5.79B
| $40.4M | 0.03% |
1,978,488
+779,700
| +65% | +$12.4M |
|
|
RPAI
496
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $40.3M | 0.03% |
5,510,166
-1,066,055
| -16% | -$6.14M |
|
497
Apple Hospitality REIT
APLE
$3.75B
| $40.2M | 0.03% |
4,165,788
-227,300
| -5% | -$2.16M |
|
498
Unitil
UTL
$992M
| $40.2M | 0.03% |
897,028
-47,823
| -5% | -$2.34M |
|
499
Moody's
MCO
$84.6B
| $40.2M | 0.03% |
146,200
-311,422
| -68% | -$79.1M |
|
500
Chevron
CVX
$388B
| $40M | 0.03% |
+448,084
| New | +$40.1M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.